Glucagon-like peptide-1 receptor agonist use is associated with lower serum periostin
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2023 |
|---|---|
| Erschienen: |
2023 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:53 |
|---|---|
| Enthalten in: |
Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology - 53(2023), 4 vom: 01. Apr., Seite 469-473 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Foer, Dinah [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Glucagon-Like Peptide-1 Receptor |
|---|
| Anmerkungen: |
Date Completed 17.04.2023 Date Revised 02.04.2024 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1111/cea.14284 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM351589732 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM351589732 | ||
| 003 | DE-627 | ||
| 005 | 20240402235342.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2023 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1111/cea.14284 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1361.xml |
| 035 | |a (DE-627)NLM351589732 | ||
| 035 | |a (NLM)36648098 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Foer, Dinah |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Glucagon-like peptide-1 receptor agonist use is associated with lower serum periostin |
| 264 | 1 | |c 2023 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 17.04.2023 | ||
| 500 | |a Date Revised 02.04.2024 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 650 | 4 | |a Letter | |
| 650 | 4 | |a Research Support, N.I.H., Extramural | |
| 650 | 4 | |a Research Support, Non-U.S. Gov't | |
| 650 | 7 | |a Glucagon-Like Peptide-1 Receptor |2 NLM | |
| 700 | 1 | |a Beeler, Patrick E |e verfasserin |4 aut | |
| 700 | 1 | |a Cui, Jing |e verfasserin |4 aut | |
| 700 | 1 | |a Snyder, William E |e verfasserin |4 aut | |
| 700 | 1 | |a Mashayekhi, Mona |e verfasserin |4 aut | |
| 700 | 1 | |a Nian, Hui |e verfasserin |4 aut | |
| 700 | 1 | |a Luther, James M |e verfasserin |4 aut | |
| 700 | 1 | |a Karlson, Elizabeth W |e verfasserin |4 aut | |
| 700 | 1 | |a Boyce, Joshua A |e verfasserin |4 aut | |
| 700 | 1 | |a Cahill, Katherine N |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology |d 1990 |g 53(2023), 4 vom: 01. Apr., Seite 469-473 |w (DE-627)NLM012617121 |x 1365-2222 |7 nnns |
| 773 | 1 | 8 | |g volume:53 |g year:2023 |g number:4 |g day:01 |g month:04 |g pages:469-473 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1111/cea.14284 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 53 |j 2023 |e 4 |b 01 |c 04 |h 469-473 | ||